Background: Maternal hypoxia induces sustained fetal adaptations associated with changes in gene expression. We hypothesized that intermittent maternal hypoxia has an influence on regional expression of endothelial nitric oxide synthase (eNOS) in fetal arteries of New Zealand White rabbits. Methods: Timed-pregnant New Zealand White rabbits (term = 30 ± 1 d) were randomly assigned to a normoxic control group (n = 5) or a hypoxia group (12% O 2 , n = 5) during days 10-29 of pregnancy. At the end of pregnancy (29 d gestation), blood samples were collected from mothers and fetuses. Carotid and femoral arteries of fetuses were extracted for eNOS mRNA and protein concentration and analysis of total NOS activities. results: Our data demonstrate that chronic intermittent maternal hypoxia significantly increased eNOS mRNA and protein concentrations and total NOS activities in carotid artery segments but decreased eNOS mRNA and protein concentrations and total NOS activities in femoral artery segments in the same fetuses. Vascular endothelial cells, but not smooth muscle cells, of fetal rabbits exhibited positive immunostaining for the eNOS protein. conclusion: These observations suggest that chronic hypoxia can regulate regional expression of eNOS as an adaptive response to hypoxic stress in fetal arteries.
h ypoxia is the most important and clinically relevant stress to which the fetus is exposed (1) (2) (3) . Many conditions in pregnant women, including exposure to high altitude; smoking; exposure to environmental pollution with carbon monoxide; anemia; placental insufficiency; cord compression; preeclampsia; diseases of the heart, lung, and kidney; or hemoglobinopathy can cause hypoxemic stress to the fetus (1) . The compensatory responses of the fetus to hypoxia are variable and depend on the duration and severity of hypoxic exposure. Cardiovascular responses to acute hypoxic stress include neuroreflex and endocrine responses, which result in decreases in fetal heart rate, increases in mean arterial pressure, and fetal cardiac output redistribution (4) . Prolonged exposure to hypoxia induces sustained fetal adaptations associated with changes in gene expression, fetal growth restriction, and organspecific growth (5, 6) . It has been clearly demonstrated that one of the important fetal adaptations to either acute or sustained hypoxia is a redistribution of fetal cardiac output to ensure a preferential supply of nutrients to the brain and the heart and maintain their growth at the expense of the periphery (7, 8) . The redistribution of fetal cardiac output during hypoxia may partially depend on the balance between vasomotor influences of circulating catecholamines (9) and those of endotheliumderived relaxing factors such as nitric oxide (NO) (10) .
NO is an important physiologic modulator of blood flow and is derived from three isoforms of NO synthase (NOS): endothelial NOS (eNOS, NOS-3), inducible NOS (NOS-2), and neuronal NOS (NOS-1) (11) . Endothelial cell-generated NO accounts for a large part of the labile vasodilator termed "endothelium-derived relaxing factor" (12) , and it plays an important role in modulating relaxation of the underlying vascular smooth muscle via the cyclic guanosine monophosphate synthesis pathway (eNOS-NO-cyclic guanosine monophosphate pathway) (13, 14) . Williams et al. (15) reported that NO is the primary vasodilator molecule released from the endothelium of both mature and immature ovine carotid arteries. Thompson et al. (16, 17) demonstrated the important role of NO in enhanced fetal carotid artery vasodilation in response to prolonged maternal hypoxia; subsequently, they reported that chronic maternal hypoxia in a 12% O 2 atmosphere (14 d) increased eNOS protein levels in fetal carotid arteries by fourfold (18) .
To determine whether a reduced oxygen supply in utero has a differential effect on eNOS expression among different vascular tissues within the same fetus, we investigated the effects of chronic intermittent maternal hypoxia on eNOS expression in two distinct arteries in fetal rabbits: the carotid artery, which supplies blood to the brain, and the femoral artery, which supplies the periphery. Quantification of the changes in eNOS expression in the fetal arteries is an important step in understanding how chronic hypoxia can regulate NO production as
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RESULTS

Maternal and Fetal Blood Sample Values
We measured erythropoietin (EPO) as an index of maternal hypoxemia and measured hematocrit, red blood cell (RBC) count, and EPO as indexes of fetal hypoxemia (Figure 1) . Chronic maternal hypoxia significantly increased maternal EPO (P < 0.05) and fetal hematocrit (P < 0.01), RBC count (P < 0.01), and EPO (P < 0.05) values as compared with the respective control. These results show that chronic maternal hypoxia induced significant maternal and fetal hypoxemia.
Fetal Weights and Organ-to-Body Weight Ratios
The birth weights of maternal hypoxia fetuses were significantly reduced as compared with those of control fetuses (57.91 ± 4.21 vs. 62.04 ± 3.27 g; P <0.05). In addition, the brainto-body weight ratio and heart-to-body weight ratio were significantly (P < 0.05) higher, and the liver-to-body weight ratio was significantly lower (P < 0.01) in maternal hypoxia fetuses as compared with controls. But there were no obvious differences in mean weight ratios of the lung and kidney (Figure 2) . These results indicate that maternal exposure to hypoxia resulted in disproportionate intrauterine growth restriction of fetal organs.
eNOS Protein
The effect of hypoxia on eNOS protein expression in fetal carotid (Figure 3a) and femoral arteries (Figure 3c ) was quantified by western blot analysis. eNOS protein was identified by single 140-kDa bands in both fetal carotid and femoral artery samples. Carotid (Figure 3b ) and femoral (Figure 3d ) artery β-actin (42 kDa) bands showed equal loading of the samples. eNOS protein bands were quantified by densitometry and the average optical density values plotted in the corresponding figures.
eNOS protein was constitutively expressed in both the fetal carotid and femoral arteries of the control and maternal hypoxia groups. The results are shown as a ratio of eNOS to β-actin densitometry (Figure 3e ), which illustrates a significant increase (P < 0.05) in eNOS protein in carotid arteries from maternal hypoxia fetuses as compared with control fetuses. By contrast, eNOS protein levels in femoral arteries from maternal hypoxia fetuses were significantly lower (P < 0.05) than those of control fetuses. Figure 4 illustrates the activities of total NOS in fetal artery segments. Similar to eNOS protein levels, maternal hypoxia significantly increased total NOS activities of fetal carotid artery segments (P < 0.05) and decreased the enzyme activity in fetal femoral artery segments (P < 0.05).
Total NOS Activities
eNOS mRNA eNOS mRNA levels in fetal artery segments were quantified using real-time reverse-transcriptase PCR and expressed as 2-ΔΔ cycle threshold (C t ) values. Figure 5 illustrates the average eNOS mRNA of isolated fetal carotid and femoral artery segments from the same fetuses. Maternal hypoxia Figure 1 . Effect of chronic intermittent maternal hypoxia on (a) fetal hematocrit, (b) red blood cell (RBC) count, and (c) maternal and fetal erythropoietin (EPO) concentration. All data are expressed as means ± SD for control (white bars; maternal n = 5 and fetal n = 10) and maternal hypoxia (black bars; maternal n = 5 and fetal n = 10) animals. *P < 0.05; **P < 0.01, as compared with control. Organ weight-to-body weight ratios of brain, heart, lung, liver, and kidneys in control (white bars, n = 10) and maternal hypoxia (black bars, n = 10) fetuses. *P < 0.05; **P < 0.01, as compared with control. significantly increased eNOS mRNA levels of fetal right common carotid artery segments (P < 0.01) and decreased mRNA values of fetal right femoral artery segments (P < 0.05). This identifies a distinct effect of hypoxia on eNOS mRNA expression that differs within fetal arteries and is regionally specific.
Immunohistochemical Analysis
Immunohistochemistry revealed eNOS to be localized only within endothelial cells in fetal artery preparations. Immunoreactivity to eNOS in carotid arteries from maternal hypoxia fetuses (Figure 6c ) showed a significant increase in staining intensity vs. controls (Figure 6a ). By contrast, immunoreactivity to eNOS in femoral arteries from maternal hypoxia fetuses (Figure 6g ) showed a significant decrease in staining intensity vs. controls (Figure 6e) . A significant difference was found in the expression of eNOS with average optical density of positive cells in the fetal carotid arteries (P < 0.05) as well as femoral arteries (P < 0.01) between the maternal hypoxia and control groups (Figure 7 ).
DISCUSSION
The regulation of arterial blood flow is crucial for growth and survival of the fetus during hypoxia. However, the adaptive mechanisms of the fetal vasculature to chronic hypoxia during pregnancy are unclear, and endothelium-derived NO may play an important role in enhanced fetal artery vasodilation in response to chronic hypoxia (16) (17) (18) . To our knowledge, the current study is the first to determine the impact of chronic maternal hypoxia on eNOS gene expression in distinct arteries in the same fetus.
To determine whether 19 d of maternal intermittent hypoxia with 12% O 2 induces fetal hypoxemia, we measured EPO as an index of maternal hypoxemia and measured hematocrit, RBC count, and EPO as indexes of fetal hypoxemia. Our data demonstrated that chronic intermittent maternal hypoxia significantly increased maternal EPO (P < 0.05) and fetal hematocrit (P < 0.01), RBC count (P < 0.01), and EPO (P < 0.05) values as compared with controls, suggesting that chronic intermittent maternal hypoxia induced significant maternal and fetal hypoxemia, which is consistent with previous results (17,18). . Endothelial nitric oxide synthase (eNOS) mRNA levels of isolated fetal carotid and femoral artery segments of control (white bars, n = 5) and maternal hypoxia (black bars, n = 5) fetuses. mRNA expression levels are measured as the 2-ΔΔC t values and compared between control and maternal hypoxia animals. *P < 0.05; **P < 0.01, as compared with control. 
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Our data showed that a reduction in maternal oxygen supply during days 10-29 of gestation resulted in reduced fetus size and perturbations of fetal organ weight and proportion, the latter suggesting fetal organ-specific growth. Previous studies showed that chronic maternal hypoxia of different severity and at different gestational ages in pregnant rats reduces fetal (19) or neonatal (20, 21) body weight and alters fetal organ growth. Conservation of brain and heart growth and reduced liver growth in fetuses after maternal hypoxia suggest that chronic maternal hypoxia caused changes in peripheral and/ or central artery resistance that redistributed cardiac output. The vascular resistance may depend on the balance between vasomotor influences of circulating catecholamines (9,10) and of endothelium-derived relaxing factors such as NO (10) . Our study illustrates a differential effect of chronic intermittent maternal hypoxia on eNOS protein and mRNA expression in the common carotid and femoral artery segments of fetal rabbits. With intermittent maternal hypoxia, the fetal common carotid artery showed higher levels of eNOS mRNA, protein, and total NOS activities than did control tissue. The mRNA, protein, and enzyme expressions in the femoral artery were lower after hypoxia than those found in control tissues. Our study demonstrates that eNOS is immunolocalized in the vascular endothelial cells but not in vascular smooth muscle cells, which is similar to previous results (22) . The current study demonstrates that chronic intermittent maternal hypoxia induces an altered eNOS gene expression in common carotid and femoral artery segments of fetal rabbits, and that regional selectivity of the effects on chronic hypoxia may contribute to the redistribution of fetal cardiac output during hypoxia.
Hypoxia alters the endothelial properties of fetal pulmonary (23), fetal carotid (16, 17) , cerebral (24) , and femoral arteries (10, 25, 26) . The effect of chronic hypoxia on fetal tissue eNOS gene expression is variable among different cell types. For example, chronic maternal hypoxia with 12% O 2 for 14 d increases eNOS protein levels in fetal guinea pig carotid artery segments, whereas there is no effect on eNOS in fetal hearts of the same animals (18) . The same group also reported that chronic maternal hypoxia of 10.5% O 2 for 14 d upregulates eNOS mRNA and protein expression in coronary arteries from fetal guinea pigs, although it downregulates mRNA and protein expression in cardiac tissue of the same animals (27) . Chronic exposure to hypoxia can reduce sensitivity to acetylcholine by lowering NO release in the chicken embryo femoral artery (25) , which is consistent with our results that chronic maternal hypoxia decreased the expression of eNOS activities in fetal femoral artery segments.
The mechanisms underlying this regional variability in eNOS protein expression in response to chronic hypoxia in vivo are not currently clear and may be related to hypoxia per se or changes of arterial shear stress. It is not unlikely that hypoxia per se may have different regulatory effects on eNOS protein and mRNA in different vascular beds. However, studies (12, 28, 29) in cultured endothelial cells have yielded conflicting results of the effects of 24-h hypoxia on eNOS protein and mRNA expression. Arterial shear stress may also influence the expression of the eNOS gene. Because a shear stressresponsive element has been characterized in the promoter . Average optical density of endothelial nitric oxide synthase of fetal carotid and femoral arteries. *P < 0.05; **P < 0.01, maternal hypoxia (black bars) as compared with control (white bars). sequence of the human and bovine eNOS gene (30) (31) (32) , the changes in blood flow occurring during fetal hypoxemia may alter arterial shear stress (26) , which in turn can modulate the expression and activity of eNOS (33) . One of the well-studied signaling pathways activated during endothelial response to shear stress is the cascade consisting of G-protein → phospholipase C/Ca 2+ → protein kinase C → c-fos/c-jun → activator protein 1 site-dependent transcription; this pathway is operative in the elevation of eNOS expression by shear stress. Therefore, in the current study, the hypoxia-induced increase in carotid artery eNOS expression may be induced either by a direct effect of hypoxia on the endothelium or indirectly via enhanced carotid artery blood flow. Because the redistribution of fetal cardiac output occurs away from the periphery during fetal hypoxemia (8, 34) , we speculate that the decrease in femoral artery blood flow leads to reduced shear stress, which in turn may result in a decrease in arterial eNOS expression (35) .
It has been demonstrated that endothelium-derived NO in the fetal circulation is a potent vasodilator responsible for modulating fetal vascular reactivity (36, 37) and organ blood flow (38, 39) . Chronic hypoxia may induce sustained release of endothelium-derived NO, thereby causing long-term changes in responsiveness to the underlying vascular smooth muscle. In our study, we speculate that chronic intermittent maternal hypoxia may induce intermittent release of endothelium-derived NO and redistribution of cardiac output. Our data suggest that chronic maternal hypoxia significantly increased eNOS expression in carotid arteries; thus, endothelium-derived NO may increase, contributing to decreased carotid artery tone and increased central blood flow. In addition, maternal hypoxia significantly decreased eNOS expression in femoral arteries; thus, endothelium-derived NO may decrease, contributing to increased femoral artery tone, decreased peripheral blood flow, and conservation of brain and heart perfusion.
In summary, previous studies have demonstrated an important role of eNOS in vascular function. The current study demonstrates that chronic intermittent maternal hypoxia alters eNOS gene expression in the carotid artery endothelium differently than in the femoral artery endothelium. The functional roles of differential eNOS expression in response to chronic hypoxia in vivo are not currently clear, but it may be an important adaptive response during hypoxia in modulating arterial reactivity.
METHODS
Animal Model
All experimental procedures were in accordance with National Institutes of Health guidelines with approval by the Standing Committee on Ethics and Animal Experimentation at the Fujian Medical University (China). Pregnant New Zealand White rabbits (Shanghai Experimental Animal Center, Shanghai, China) were time mated (term = 30 ± 1 d). On day 10, rabbits were randomized to normoxic control and maternal hypoxia groups. Throughout pregnancy, rabbits were housed individually in standard rabbit cages, which were maintained in a clean conventional facility, with 55% humidity and a room temperature of 23 °C, natural light, and ad libitum access to food (standard lab rabbit chow) and water.
Intermittent Maternal Hypoxia
According to the procedure of Wang et al. (40) , from day 10 to day 29 of pregnancy, five pregnant rabbits were placed inside a plexiglass chamber twice per day, 4 h in the morning and 4 h in the afternoon. The oxygen supply was then reduced to 12 ± 0.5% oxygen by continuous infusion of a nitrogen gas and compressed air mixture. The expired carbon dioxide was eliminated by circulating the atmosphere through soda lime, and the water contained in the expired gas was trapped in a chilled glass tank. A portable oxygen analyzer (IST-AIM, Chicago, IL) was calibrated daily and used to monitor the oxygen concentration of the chamber. Normoxic controls (n = 5) were put into an identical plexiglass chamber, into which compressed air was continuously infused. They then underwent the same procedures as the animals exposed to hypoxia.
Tissue and Blood Collection
At near term (29 d of gestation), pregnant mothers were anesthetized with i.v. sodium amobarbital (30 mg/kg; Amresco, Solon, OH), and control and maternal hypoxia fetuses were removed from the abdomen via a hysterotomy. All the fetuses were weighed. Blood samples were collected into tubes treated with EDTA dipotassium salt dihydrate from the aorta of anesthetized adults and via cardiac puncture from two fetuses per litter from control and maternal hypoxia litters. Aliquots of blood were analyzed on a hematology analyzer (HV950FS; Drew Scientific, Waterbury, CT). The remaining portion of the blood sample was centrifuged (Allegra X-22R; Beckman, Palo Alto, CA) at 1,000g and 4 °C for 30 min, and aliquots of plasma were stored at −70 °C for measurement of EPO. Common carotid and femoral arteries, which were gently isolated from fetuses, were cleaned of adherent tissue and flash-frozen in liquid nitrogen and stored at −70 °C for subsequent western blot determination of eNOS content, colorimetric determination of total NOS activities, and real-time reverse-transcriptase PCR analysis of eNOS mRNA abundance. For immunohistochemical staining of eNOS protein, the right common carotid arteries, which were isolated from one fetus per litter from control and maternal hypoxia litters, were cut into rings 1.5 cm in length and further fixed with 10% formalin overnight. Tissues were processed by standard procedures in graded alcohols and xylene, paraffin embedded, and stored at room temperature. Brain, heart, lung, liver, and kidneys were dissected from two fetuses per litter for the determination of relative weights.
EPO Enzyme-Linked Immunosorbent Assay
Plasma levels of EPO were analyzed using an ELISA Kit (ADL, Westchester, NY) per the manufacturer's instructions.
Quantitative Western Blot Analysis of eNOS eNOS protein content was evaluated with standard western immunoblot. Because of the small size of the isolated carotid and femoral arteries, two left common carotid arteries and two left femoral arteries were obtained from two different fetuses from the same litter and pooled as a single sample, representing an n value of 1. Artery segments were homogenized using lysis buffer, homogenates were centrifuged at 12,500g at 4 °C for 5 min, and the soluble protein content of the supernatant was determined by a bicinchoninic acid protein assay kit (Beyotime Biotechnology, Shanghai, China). For western immunoblot, 30 μg of total protein were loaded on gels and separated by electrophoresis and membrane transfer. The gels were probed by a specific eNOS antibody (anti-eNOS, 1:200 dilution; Boster, Wuhan, China). As a loading control, β-actin was also detected with anti-β-actin antibody (1:1,000 dilution; Beyotime Biotechnology). Proteins were visualized using enhanced chemiluminescence reagents (Beyotime Biotechnology). The intensity of bands was analyzed with Quantity One v4.62 analyzer software (Bio-Rad, Hercules, CA). The results are expressed as a ratio of the density of the eNOS band to the β-actin band.
Determination of Total NOS Activities by Colorimetric Method
Arterial total NOS activities were determined using the NOS assay kit (A014; Jiancheng Bioengineering, Nanjing, China) and the manufacturer's protocol. The activity of total NOS was assayed by nitrites and nitrates produced from l-arginine. In brief, the supernatants of
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Quantification of eNOS mRNA by Real-Time ReverseTranscriptase PCR Total RNA was extracted from the right common carotid arteries and right femoral arteries by TRIzol (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. RNA concentrations were determined by spectrophotometry at 260 nm (ND-1000; Thermo, Wilmington, DE). cDNA was synthesized using SuperScript II (Invitrogen) and random hexonucleotide primers. eNOS sequences were obtained from National Center for Biotechnology Information/ GenBank databases. Primer 3 software (http://frodo.wi.mit.edu/ primer3/) was used to design the primers. The following sequences were used as primers for eNOS and β-actin: 5′-CAA GAC CTA CGT GCA GGA CAT C-3′ (forward) and 5′-AAG GAG AAA CTC TGG GTG CGT A-3′ (reverse), and 5′-ATC AAG GAG AAG CTG TGC TAC G-3′ (forward) and 5′-AGG AAG GAG GGC TGG AAG AG-3′ (reverse), respectively. Real-time PCR was performed with an iCycler using SYBR Premix Ex Taq (TaKaRa Biotechnology, Dalian, China). The two-step quantification cycling protocol was used. eNOS mRNA expression was normalized to that of the housekeeping gene β-actin mRNA and quantified by the 2-ΔΔC t method (41) .
Immunohistochemistry for eNOS
Three consecutive 5-μm sections from each specimen were deparaffinized in a standard series of xylenes and graded alcohols. Antigen retrieval was performed in 0.01 mol/l citrate buffer (pH 6.0). Slides were placed in a beaker of citrate buffer, and this beaker was placed in a separate, larger beaker of boiling water. Slides were kept in citrate buffer in boiling water for 10 min and then cooled in buffer to room temperature. Subsequently, we used the Ultrasensitive Streptavidin-Peroxidase Kit (KIT-9706; Maixin-Bio, Fuzhou, China), and immunohistochemical analysis was performed by the streptavidin-peroxidase method. The primary antibody used was a rabbit polyclonal antibody against eNOS (1:100 dilution; Boster). Negative-control sections were incubated in blocking buffer alone without primary antibody. Each section underwent 3,3′-diaminobenzidene (DAB-0031; Maixin-Bio) staining and hematoxylin restaining. For each section of areas selected to include only the endothelium, five fields were randomly chosen, and the values of the average optical density were measured under the same magnification (original magnification ×600) using a color image analysis system.
Statistical Analyses
Relative organ weights were measured as a ratio of the fetal organ weight normalized to the respective body weight. eNOS mRNA levels obtained were measured as 2-ΔΔC t values. Results were presented as grouped means ± SD. The unpaired Student's two-tailed t-test was used for comparing two groups wherever appropriate, and two-way ANOVA was used for comparisons among more than two groups. Probability values of <0.05 were considered statistically significant. All data analyses were performed with Statistical Product and Service Solutions 11.5 (SSPS 11.5; SSPS, Chicago, IL).
